Literature DB >> 8174076

Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo.

M A Versnel1, M Haarbrink, A W Langerak, P A de Laat, A Hagemeijer, T H van der Kwast, L A van den Berg-Bakker, P I Schrier.   

Abstract

In human malignant mesothelioma cell lines an elevation of the expression of the genes for the PDGF A-chain, PDGF B-chain, and PDGF beta-receptor was found compared to normal mesothelial cells. As ovarian epithelial tumors originate from the ovarian surface epithelium, which is of mesothelial origin, we investigated PDGF chain and PDGF receptor mRNA expression in six human ovarian cell lines of epithelial origin and a granulosa tumor cell line. All six investigated ovarian epithelial tumor cell lines expressed the PDGF A- and B-chain genes, while the granulosa tumor cell line expressed the PDGF A-chain gene only. Expression of PDGF receptors was not found in the epithelial or granulosa tumor cell lines. Cytogenetic and molecular biological studies did not provide evidence for rearrangement or genomic amplification of the PDGF B-chain. Expression of PDGF was also demonstrated in ovarian tumors in vivo. Frozen sections of six serous ovarian carcinomas stained positive with an antibody against PDGF and negative with antibodies against the PDGF alpha- and beta-receptors. These results suggest that PDGF expression might be a useful marker for ovarian carcinomas.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174076     DOI: 10.1016/0165-4608(94)90183-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Platelet Derived Growth Factor BB: A "Must-have" Therapeutic Target "Redivivus" in Ovarian Cancer.

Authors:  Anca Maria Cimpean; Ionut Marcel Cobec; Raluca Amalia Ceaușu; Roxana Popescu; Anca Tudor; Marius Raica
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

Review 2.  Cytokines in tumour growth, migration and metastasis.

Authors:  R P Negus; F R Balkwill
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

3.  Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice.

Authors:  Hanna Sallinen; Maarit Anttila; Johanna Narvainen; Jonna Koponen; Kirsi Hamalainen; Ivana Kholova; Tommi Heikura; Pyry Toivanen; Veli-Matti Kosma; Seppo Heinonen; Kari Alitalo; Seppo Yla-Herttuala
Journal:  Mol Ther       Date:  2008-12-02       Impact factor: 11.454

4.  Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.

Authors:  Tatiana M Tilli; Akeila Bellahcène; Vincent Castronovo; Etel R P Gimba
Journal:  BMC Cancer       Date:  2014-06-13       Impact factor: 4.430

5.  Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling.

Authors:  Shreya Raghavan; Catherine S Snyder; Anni Wang; Karen McLean; Dmitriy Zamarin; Ronald J Buckanovich; Geeta Mehta
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

6.  Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma.

Authors:  Marta Mendiola; Jorge Barriuso; Andrés Redondo; Adrián Mariño-Enríquez; Rosario Madero; Enrique Espinosa; Juan Angel Fresno Vara; Iker Sánchez-Navarro; Ginés Hernández-Cortes; Pilar Zamora; Elia Pérez-Fernández; María Miguel-Martín; Asunción Suárez; José Palacios; Manuel González-Barón; David Hardisson
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.